Literature DB >> 21146459

Mitophagy: the latest problem for Parkinson's disease.

Cristofol Vives-Bauza1, Serge Przedborski.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder of unknown cause. Some familial forms of PD are provoked by mutations in the genes encoding for the PTEN (phosphatase and tensin homolog)-induced putative kinase-1 (PINK1) and Parkin. Mounting evidence indicates that PINK1 and Parkin might function in concert to modulate mitochondrial degradation, termed mitophagy. However, the molecular mechanisms by which PINK1/Parkin affect mitophagy are just beginning to be elucidated. Herein, we review the main advances in our understanding of the PINK1/Parkin pathway. Because of the phenotypic similarities among the different forms of PD, a better understanding of PINK1/Parkin biology might have far-reaching pathogenic and therapeutic implications for both the inherited and the sporadic forms of PD.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146459     DOI: 10.1016/j.molmed.2010.11.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  57 in total

1.  PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.

Authors:  Xinnan Wang; Dominic Winter; Ghazaleh Ashrafi; Julia Schlehe; Yao Liang Wong; Dennis Selkoe; Sarah Rice; Judith Steen; Matthew J LaVoie; Thomas L Schwarz
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 2.  Regulation of mitophagy in ischemic brain injury.

Authors:  Yang Yuan; Xiangnan Zhang; Yanrong Zheng; Zhong Chen
Journal:  Neurosci Bull       Date:  2015-07-28       Impact factor: 5.203

3.  Mitophagy in Refractory Temporal Lobe Epilepsy Patients with Hippocampal Sclerosis.

Authors:  Mengqian Wu; Xinyu Liu; Xiaosa Chi; Le Zhang; Weixi Xiong; Siew Mun Vance Chiang; Dong Zhou; Jinmei Li
Journal:  Cell Mol Neurobiol       Date:  2017-04-12       Impact factor: 5.046

4.  Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation.

Authors:  Masahiro Iguchi; Yuki Kujuro; Kei Okatsu; Fumika Koyano; Hidetaka Kosako; Mayumi Kimura; Norihiro Suzuki; Shinichiro Uchiyama; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

Review 5.  Mitochondria: the next (neurode)generation.

Authors:  Eric A Schon; Serge Przedborski
Journal:  Neuron       Date:  2011-06-23       Impact factor: 17.173

6.  Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1.

Authors:  Pamela Valdés; Gabriela Mercado; Rene L Vidal; Claudia Molina; Geoffrey Parsons; Felipe A Court; Alexis Martinez; Danny Galleguillos; Donna Armentano; Bernard L Schneider; Claudio Hetz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

7.  Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson's models.

Authors:  Atossa Shaltouki; Chung-Han Hsieh; Min Joo Kim; Xinnan Wang
Journal:  Acta Neuropathol       Date:  2018-06-09       Impact factor: 17.088

8.  Voltage-dependent anion channels (VDACs) recruit Parkin to defective mitochondria to promote mitochondrial autophagy.

Authors:  Yu Sun; Ajay A Vashisht; Jason Tchieu; James A Wohlschlegel; Lars Dreier
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

9.  Low-density lipoprotein receptor-related protein-1 (LRP1) mediates autophagy and apoptosis caused by Helicobacter pylori VacA.

Authors:  Kinnosuke Yahiro; Mamoru Satoh; Masayuki Nakano; Junzo Hisatsune; Hajime Isomoto; Jan Sap; Hidekazu Suzuki; Fumio Nomura; Masatoshi Noda; Joel Moss; Toshiya Hirayama
Journal:  J Biol Chem       Date:  2012-07-22       Impact factor: 5.157

10.  Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells.

Authors:  Liliana Rojas-Charry; Mark R Cookson; Andrea Niño; Humberto Arboleda; Gonzalo Arboleda
Journal:  Neurotoxicology       Date:  2014-05-02       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.